Tiedot: Many of the below pathways, although currently in use, have not yet undergone checks for consistency with ICB commissioning and prescribing policies, as published in the APC Formulary. Until such checks are completed, where there is a discrepancy, the ICB commissioning policy or APC Formulary overrides the pathway.